Testing a new gonorrhea test for women
Part of Infections clinical trials.
This study evaluates a new rapid test for gonorrhea designed for women. You'll provide vaginal swab samples and complete a brief counseling session to help researchers understand how well the test works and whether patients can use it correctly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female and at least 17 years old
- You are willing to provide 3–4 vaginal swab samples on the same day
- You speak, read, and write English fluently
- You have a medical reason for gonorrhea testing (symptoms, recent sexual risk, or routine screening)
- You have not used vaginal antiseptics in the past 48 hours or taken antibiotics for gonorrhea in the past 7 days
- You are not currently menstruating and have not had a urogenital procedure in the past 72 hours
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether a lower dose (500 mg) of the antibiotic ceftriaxone works as well as the standard dose (1000 mg) for treating gonorrhea in men. If you have a gonorrhea infection in your throat, rectum, or genitals and are otherwise healthy, you may be able to join.
This study evaluates a new rapid blood test that checks for HIV, hepatitis B, and syphilis all at once. Researchers want to make sure the test works well, is easy to use, and gives accurate results.
This study tests a new quick test that detects gonorrhea (a sexually transmitted infection) in pregnant women and women with vaginal symptoms. The test gives results fast and could help women get treated quickly if needed.
This study checks whether a specific lab test (the “gyrA assay”) can detect gonorrhea in people who do not have symptoms. It may help clinicians find gonorrhea more quickly and with the right treatment when symptoms aren’t present.
This trial tests a new vaccine designed to protect against gonorrhea, a common sexually transmitted infection. The study checks how safe the vaccine is and how well it trains the immune system to fight the bacteria.
This study looks at throat samples from people who may have been exposed to gonorrhea to better understand how the bacteria grow there. It may help improve testing and treatment for partners.
Hear when a new Gonorrhea Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.